 |
 |

The Value of Tests Predicting Renovascular Hypertension in Patients With Renal Artery Stenosis Treated by Angioplasty
Cornelis T. Postma, MD;
Aernout H. A. M. van Oijen, MD;
Jelle O. Barentsz, MD;
Theo de Boo, MSc;
Willibrord H. L. Hoefnagels, MD;
Frans H. M. Corstens, MD;
Theo Thien, MD
Arch Intern Med. 1991;151(8):1531-1535.
Abstract
The aim of this study was to evaluate tests predicting renovascular hypertension. This was done by relating the results of renal vein renin tests, the captopril test, and renal scintigraphic tests to the blood pressure outcome 12 months after relief of renal artery stenosis by percutaneous transluminal renal angioplasty in 31 patients. Cure was seen in eight (26%). Improved blood pressure was obtained in 12 patients (39%), and in 11 patients (35%), the result for blood pressure was a failure. The accuracies of the two mathematical models used to analyze the renal vein renin assays were 44% and 60%. The captopril test showed a sensitivity of 36% and an accuracy of 43%. Renal captopril technetium Tc 99m-labeled pentetic acid scintigraphy gave a sensitivity of 60%. Stepwise logistic regression analysis of clinical variables in relation to blood pressure response revealed age as the only factor significantly related to blood pressure outcome. We conclude that the tests used are unfit for helping select patients for percutaneous transluminal renal angioplasty and that age may have an important influence on outcome.
(Arch Intern Med. 1991;151:1531-1535)
Author Affiliations
From the Division of General Internal Medicine, Department of Medicine (Drs Postma, van Oijen, Hoefnagels, and Thien), Department of Diagnostic Radiology (Dr Barentsz), Department of Medical Statistics (Mr de Boo), and Department of Nuclear Medicine (Dr Corstens), University Hospital, Nijmegen, the Netherlands.
Footnotes
Accepted for publication December 14, 1990.
Reprint requests to Division of General Internal Medicine, Department of Medicine, University Hospital, PO Box 9101, 6500 HB Nijmegen, the Netherlands (Dr Postma).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Renovascular Hypertension and Ischemic Nephropathy
Garovic and Textor
Circulation 2005;112:1362-1374.
FULL TEXT
Diagnosis and Treatment of Renovascular Hypertension: A Cost-Benefit Analysis
Bolduc et al.
Am. J. Roentgenol. 2005;184:931-937.
ABSTRACT
| FULL TEXT
Prediction of Clinical Response After Renal Angioplasty: Respective Value of Renal Doppler Sonography and Scintigraphy
Soulez et al.
Am. J. Roentgenol. 2003;181:1029-1035.
ABSTRACT
| FULL TEXT
Selective renal embolisation for renovascular hypertension?
Ognjanovic et al.
Arch. Dis. Child. 2002;86:127-129.
ABSTRACT
| FULL TEXT
Invited Commentary Authors' Response
Sarkar et al.
RadioGraphics 2000;20:1368-1372.
FULL TEXT
Current Perspectives on the Role of Captopril Imaging in the Diagnosis of Renovascular Disease
Collins and Gusberg
PERSPECT VASC SURG ENDOVASC THER 2000;13:43-69.
ABSTRACT
The Place of Renal Scintigraphy in the Diagnosis of Renal Artery Stenosis: Fifteen Years of Clinical Experience
van Jaarsveld et al.
Arch Intern Med 1997;157:1226-1234.
ABSTRACT
Comparison of Two Noninvasive Screening Tests for Renovascular Hypertension
Elliott et al.
Arch Intern Med 1993;153:755-764.
ABSTRACT
Newer Tests for the Diagnosis of Renovascular Disease
Davidson and Wilcox
JAMA 1992;268:3353-3358.
ABSTRACT
|